With ZYN obtaining market approval through the US PMTA process, the United States, the most crucial market for this global novel tobacco product, has welcomed its first compliant nicotine pouch product. ZYN's PMTA approval not only signifies the reduced harm and safety of nicotine pouch products meeting the strictest global standards, but also sets a precedent for other nicotine pouch products seeking PMTA approval.
However, the strict review mechanism of the US PMTA (Pre-Market Tobacco Product Application), especially the dynamic interpretation of the "Appropriate for the Protection of Public Health" (APPH) standard, poses core challenges for nicotine pouch companies such as complex experimental designs, uncertain standards for experimental data interpretation, and high compliance costs. Although ZYN has passed the PMTA, the toxicology data collection and comparison of HPHC exposure levels in its technical solution, behavioral and abuse potential experimental plans, as well as risk mitigation strategies for FDA review pain points such as protection of minors, have not yet been systematically broken down by the industry. This poses a significant challenge for nicotine pouch companies seeking to develop compliantly in the US.
As a leading global media and consulting firm in the new tobacco industry, 2Firsts has been dedicated to promoting compliant and high-quality development of the global industry. With the support of global compliance resources, the "Two Supremes Compliance Solutions" (2Firsts Compliance Solutions) launched by us provide manufacturers and brand owners in China and globally with cost-effective compliance services tailored to their business needs. Currently, several top new tobacco companies have entrusted 2Firsts to provide them with PMTA compliance application services in the United States.
In order to support the compliant development of nicotine pouch companies and promote the high-quality overseas expansion of Chinese enterprises, 2Firsts will organize a "Nicotine Pouch PMTA Technology Seminar" in Shenzhen on April 16th. Experts will be invited to interpret technical solutions, policy details, and market dynamics. Relevant companies are welcome to participate.
The event details and registration information are as follows:
Title of the conference: PMTA Compliance Seminar: Focus on Nicotine Pouches
2. Seminar Agenda (Draft)
1. Analysis of ZYN PMTA Application Documentation by 2Firsts Experts 2. Submission Recommendations for Nicotine Pouch Supply Chain Companies Seeking TPMF (2Firsts Expert) 3. Insights into Trends in the U.S. Nicotine Pouch Market by 2Firsts Expert 4. Video Interpretation by U.S. Compliance Experts 5. Live Q&A and Interactive Discussion
Three, time and location
Time:
April 16, 2025, from 14:00 to 17:00
Location:
Shenzhen Qianhai (Please contact the staff for the specific location after registration).
Fourthly, target attendees.
Type of Enterprise:
Nicotine pouches, nicotine oral films, brands, manufacturers, and supply chain companies of innovative nicotine lozenges in the industry.
Individual role:
Boss, executives, compliance officer, US market leader.
Fifth, Registration Method:
Seminar registration fee: 500 yuan per person.
Discount:
Sign up before March 31st to enjoy a 20% discount. The price for a two-person ticket is 800 yuan, and a three-person ticket is 1000 yuan.
Invoice: Contact staff after the event to request an invoice.
The seminar has limited seating, and registration will close once all spots are filled. On-site registration will not be available.
Registration link: https://www.huodongxing.com/event/8801160799900
Event inquiry: Email: info@2firsts.com WeChat:
Note: This event is limited to professionals in the relevant industry. The two organizations reserve the right to make the final interpretation of the event within the legal framework.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
